NSE - Delayed Quote INR

IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)

Compare
369.90 +2.00 (+0.54%)
At close: November 29 at 3:30 PM GMT+5:30
Loading Chart for IOLCP.NS
DELL
  • Previous Close 367.90
  • Open 364.10
  • Bid --
  • Ask --
  • Day's Range 364.10 - 372.85
  • 52 Week Range 330.85 - 537.70
  • Volume 120,598
  • Avg. Volume 675,670
  • Market Cap (intraday) 21.718B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 21.73
  • EPS (TTM) 17.02
  • Earnings Date Feb 4, 2025 - Feb 8, 2025
  • Forward Dividend & Yield 5.00 (1.35%)
  • Ex-Dividend Date Feb 16, 2024
  • 1y Target Est 434.00

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

www.iolcp.com

2,777

Full Time Employees

March 31

Fiscal Year Ends

Recent News: IOLCP.NS

View More

Performance Overview: IOLCP.NS

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IOLCP.NS
19.18%
S&P BSE SENSEX
10.47%

1-Year Return

IOLCP.NS
18.24%
S&P BSE SENSEX
20.60%

3-Year Return

IOLCP.NS
19.60%
S&P BSE SENSEX
39.74%

5-Year Return

IOLCP.NS
122.78%
S&P BSE SENSEX
94.02%

Compare To: IOLCP.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IOLCP.NS

View More

Valuation Measures

Annual
As of 11/29/2024
  • Market Cap

    21.72B

  • Enterprise Value

    21.41B

  • Trailing P/E

    21.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.06

  • Price/Book (mrq)

    1.31

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    10.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.72%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    20.72B

  • Net Income Avi to Common (ttm)

    1.19B

  • Diluted EPS (ttm)

    17.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.15B

  • Total Debt/Equity (mrq)

    2.03%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IOLCP.NS

View More

Company Insights: IOLCP.NS

Research Reports: IOLCP.NS

View More

People Also Watch